Scientists have combined two potent immunotherapies — an oncolytic virus and chimeric antigen receptor (CAR) T cell therapy — to target and eradicate solid tumors that are otherwise difficult to treat with CAR T therapy alone.
Inflammation linked to Alzheimer’s disease development
Scientists have discovered a direct link between the immune response to viruses and bacteria and the development of plaques in the brain that characterize Alzheimer’s disease.
Possible blood-clotting mechanism in COVID-19 found
Why so many COVID-19 patients get blood clots (thrombosis) remains uncertain. But scientists have now identified a mechanism they believe to be implicated. A particular protein triggers a part of our immune system that can boost the blood’s tendency to…
Finding cortisone alternatives with fewer side effects
Researchers are examining the beneficial effects of cortisone in order to lay the groundwork for the development of similar drugs with fewer side effects.
Subtypes and developmental pathways of innate T cells identified
Study finds T cells differentiate into memory cells before meeting antigens – a clue to developing new immunotherapy.
Severe COVID-19 despite or even due to the strong immunity
Critically ill patients present a similar or even stronger immunity against the virus than convalescent patients. This supports the theory that severe infections might be linked to an exaggerated immune reaction.
RethiNKing which immune cells are the best weapon against lung cancer
Immune cells called ‘natural killer’ (NK) cells could be a powerful weapon for fighting lung cancer, according to researchers. Studying preclinical and patient samples of small cell lung cancer (SCLC), the team revealed that NK cells – but not T cells …